Whalegun
Home

Amneal Pharmaceuticals AMRX paid Tarplin, Downs & Young $60K for lobbying in Q2 2024 · Health Issues

Trade details

Type
Lobbying report
Amount
$60,000
Quarter
Q2 2024
Stock
Amneal Pharmaceuticals AMRX
Client
Amneal Pharmaceuticals
Reported
24/07/15

Up 0.0% from last quarter

What else happened in Amneal Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/05/31~24/07/30

Amneal Pharmaceuticals's other lobbying reports

Amneal Pharmaceuticals AMRX paid Tarplin, Downs & Young $60K for lobbying in Q2 2024 · Health Issues | Whalegun